Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 2 of the 15 sources its claims cite were checked for support.
Abstract
A novel lipid inhibition peptide Leu-Leu-Val-Val-Try-Pro-Trp-Thr-Gln-Arg (PP1) (MW 1274.53 Da) was obtained from Chlorella pyenoidose using enzymatic hydrolysis, gel filtration chromatography, and LC–MS/MS. Its lipid inhibition effects indicated that the synthetic peptide PP1 exhibits a good inhibitory effect against porcine pancreatic lipase (PL) (47.95%) at 200 μg/mL, which could be attributed to its hydrogen binding into catalytic sites of PL (Ser153, Asp177, and His 264) by docking analysis. Furthermore, in 3T3-L1 cells, the synthetic PP1 remarkedly decreased the accumulation of intracellular triacylglycerol (27.9%, 600 μg/mL), which carried a similar consequence as the positive drug simvastatin (24.1%, 10 μM). Western blot revealed that PP1 inhibited the lipid accumulation and fatty acid synthesis in 3T3-L1 adipocytes in two pathways, primarily: nonalcoholic fatty liver disease (NAFLD) pathway (C/EBPα, SREBP-1c, AMPKα) and AMPK signaling pathway (SREBP-1c, PPARγ, AMPKα). In short, these results support that PP1 can be used as a potential agent against obesity.
Overview
CoChat Summary
TL;DR
This paper isolates a decapeptide from *Chlorella pyrenoidosa* (PP1: LLVVYPWTQR) and shows it inhibits porcine pancreatic lipase in vitro and reduces lipid accumulation in 3T3-L1 adipocytes. The authors conclude PP1 may be a potential anti-obesity agent.
Key findings
- From *C. pyrenoidosa*, the authors extracted about 72.4% of whole proteins and found the Alcalase hydrolysate had the strongest lipase inhibition among hydrolysates, with IC50 87.79 ± 5.12 μg/mL.
- After ultrafiltration and Sephadex G-25 separation, the peptide LLVVYPWTQR (PP1) was selected; its synthetic form had 97.06% purity and a measured molecular weight of 1274.53 Da.
- Synthetic PP1 inhibited porcine pancreatic lipase by 47.95% ± 2.3% at 200 μg/mL.
- In 3T3-L1 cells, PP1 reduced intracellular triacylglycerol to 59.82 ± 6.78 nmol/mg protein at 600 μg/mL; the abstract also reports a 27.9% decrease, compared with 24.1% for simvastatin at 10 μM.
- Western blot results indicated PP1 increased AMPKα and decreased C/EBPα, SREBP-1c, and PPARγ, with the discussion stating these effects map to the NAFLD pathway and AMPK signaling pathway.
Methods
- Proteins from *C. pyrenoidosa* were enzymatically hydrolyzed with pepsin, papain, trypsin, and Alcalase, then fractionated by ultrafiltration, gel filtration chromatography (Sephadex G-25), and LC–MS/MS identification.
- The shortlisted peptide PP1 was chemically synthesized and tested for pancreatic lipase inhibition, followed by molecular docking against PL structure 1ETH with Orlistat and simvastatin as controls.
- Anti-lipid effects were assessed in 3T3-L1 adipocytes using MTT, Oil Red O staining, triglyceride measurement, and Western blot for adipogenesis-related proteins.
Limitations
- The paper states that the in vivo effects of PL inhibitors/PP1 remain for future work and that the structure–activity relationship will need further study.
- Evident from the text: the cellular anti-obesity results are based on 3T3-L1 cells only, so they do not directly establish effects in animals or humans.
- Evident from the text: the authors report docking and in vitro assays, but no direct experimental validation of the predicted binding mechanism in the enzyme is described.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 1 Not valid · 8 Not checked · 26 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Previous reports have shown that lipase inhibitors can effectively reduce fat absorption to suppress weight gain in obese patients [13,18].”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > 3. Discussion
What the sources say
- Not checked yetcites [13] Yun, 2010, Possible anti-obesity therapeutics from nature--a review, Phytochemistry source
- Partly supportedcites [18] Kim, Y.S., Lee, Y., Kim, J., Sohn, E., Kim, C.S., Lee, Y.M., Jo, K., Shin, S., Song, Y., and Kim, J.H. (2012). Inhibitory Activities of Cudrania tricuspidata Leaves on Pancreatic Lipase In Vitro and Lipolysis In Vivo. Evid. Based Complement Alternat. Med. sourceExperimental — accuracy not yet measured
The Introduction (p. 1) does state the mechanism half of the claim: inhibition of dietary fat absorption is 'a logical target for managing obesity', 'inhibitors of digestive lipases are suggested to function as antiobesity agents', and orlistat 'inhibits the action of gastrointestinal lipase and thus reduces absorption of dietary fat'; the Conclusion likewise says C. tricuspidata leaves 'are able to suppress dietary fat absorption in vivo'. However, the paper carries no evidence of suppressed weight gain in obese patients: its only in vivo work (Methods 2.2/2.5 and Results 3.2) is an acute post-load test in healthy, non-obese Wistar rats (fasted, single oral lipid emulsion, plasma triacylglycerol at 0–4 h), with effects weaker than orlistat, and no obesity model, no chronic feeding and no body-weight outcome. Weight-gain reduction appears in our copy only inside the title of a cited work (ref 17, Karu et al., Panax ginseng saponin, 2007), not as this paper's finding, so the 'suppress weight gain in obese patients' portion attributed here is unsupported. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A novel lipid inhibition peptide Leu-Leu-Val-Val-Try-Pro-Trp-Thr-Gln-Arg (PP1) (MW 1274.53 Da) was obtained from Chlorella pyenoidose using enzymatic hydrolysis, gel filtration chromatography, and LC–MS/MS.”
- Also stated in: § 2.4. Identification of PL Inhibitory Peptides · plain
“a short peptide LLVVYPWTQR (PP1) was selected for further study, which can also properly bind to PL surface using Pep-site (http://pepsite2.russelllab.org/).”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.4. Identification of PL Inhibitory Peptides · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“STRING analysis revealed that the altered proteins (AMPK-α, C/EBPα, SREBP-1c, and PPARγ) are mapped into a core network (Figure 3e), which was primarily associated with two pathways: nonalcoholic fatty liver disease (NAFLD) pathway (C/EBPα, SREBP-1c, AMPKα) and AMPK signaling pathway (SREBP-1c, PPARγ, AMPKα).”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > 3. Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In this study, about 72.4% of whole proteins were extracted from C. pyenoidose by using a series of steps [17].”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > 2. Results > 2.1. Characterization of the Extracted Proteins and Enzymatic Hydrolysates
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which could be attributed to its hydrogen binding into catalytic sites of PL (Ser153, Asp177, and His 264) by docking analysis.”
- Also stated in: § 2.6. Docking Studies · plain
“the effective docking of PP1 into the active site of PL revealed that the porcine lipase inhibitory activity of PP1 is involved in its binding to catalytic sites of the lipase (Ser153, Asp177, and His 264).”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.6. Docking Studies · plain
15 more claims
Create a free account to see all 37 claims and to verify the 13 references still open.
- Probably not a substantial claim. 6
- Borderline: one of the tests for a substantial claim is unclear. 1
- It may state two separate claims as one. 12
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several algal peptides have been identified to exert anti-obesity effects through the activation of AMP-activated protein kinase (AMPK). Notably, peptides derived from Limnospira platensis, Auxenochlorella pyrenoidosa, and the macroalgae Ulva lactuca have demonstrated such activity [115,119].”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Algal peptides naturally inhibit pancreatic lipase, thereby decreasing the amount of dietary fat that gets absorbed [115].”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [115]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A novel anti-lipidemic decapeptide PP1 (Leu-Leu-Val-Val-Trp-Pro-Trp-Thr-Gln-Arg) isolated from Auxenochlorella pyrenoidosa (formerly Chlorella pyrenoidosa) (Chlorophyta) via enzymatic hydrolysis inhibited porcine pancreatic lipase by 47.95% at 200 µg/mL”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [115]
The cited source says what the claim attributes to it.
In the citing paper
“and in 3T3-L1 adipocytes reduced triacylglycerol accumulation by 27.9% at 600 µg/mL [115].”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > Abstract
“A novel lipid inhibition peptide Leu-Leu-Val-Val-Try-Pro-Trp-Thr-Gln-Arg (PP1)”
§ Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose > 4. Materials and Methods > 4.7. Peptide Synthesis
“the biological peptide LLVVYPWTQR (PP1) was chemically synthesized by GenScript Corporation”
Citations
Cites
Pancreatic lipase inhibitors from natural sources: Unexplored potential
Birari, R. B., & Bhutani, K. K. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.024 · Cited by 871
Possible anti-obesity therapeutics from nature--a review
Yun, J. W. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.07.011 · Cited by 619 · cited 1×
“Previous reports have shown that lipase inhibitors can effectively reduce fat absorption to suppress weight gain in obese patients [13,18].”
BackgroundSheih, I.-C., Fang, T. J., & Wu, T.-K. (2009) · Food Chemistry · doi:10.1016/j.foodchem.2008.12.019 · Cited by 280 · cited 1×
“It is reported that Chlorella has certain functional properties, such as antioxidant [7], anti-inflammatory [8], antihypertensive [9], antitumor activities [2], etc.”
BackgroundHuman digestive and metabolic lipases—A brief review
Mukherjee, M. (2003) · Journal of Molecular Catalysis B Enzymatic · doi:10.1016/s1381-1177(03)00052-3 · Cited by 217 · cited 1×
“For humans, pancreatic lipase is a key lipase for lipid absorption throughout the body and is responsible for the hydrolysis of total dietary fats [10].”
BackgroundGrove, K. A., Sae‐Tan, S., Kennett, M. J., & Lambert, J. D. (2012) · Obesity · doi:10.1038/oby.2011.139 · Cited by 139
Separation, antitumor activities, and encapsulation of polypeptide from Chlorella pyrenoidosa
Wang, X., & Zhang, X. (2013) · Biotechnology Progress · doi:10.1002/btpr.1725 · Cited by 132 · cited 2×
“It is reported that Chlorella has certain functional properties, such as antioxidant [7], anti-inflammatory [8], antihypertensive [9], antitumor activities [2], etc.”
BackgroundSelf-citationAntioxidant activity of protein hydrolysates and purified peptides from Zizyphus jujuba fruits
Memarpoor-Yazdi, M., Mahaki, H., & Zare-Zardini, H. (2013) · Journal of Functional Foods · doi:10.1016/j.jff.2012.08.004 · Cited by 119 · cited 1×
“Bioactive peptides from various sources have certain functions, such as antitumor effects [2,3], antihypertensive effects [4], antioxidant activity [5,6], etc.”
BackgroundEnzyme-Assisted Discovery of Antioxidant Peptides from Edible Marine Invertebrates: A Review
Chai, T.-T., Law, Y.-C., Wong, F.-C., & Kim, S.-K. (2017) · Marine Drugs · doi:10.3390/md15020042 · Cited by 114 · cited 1×
“Bioactive peptides from various sources have certain functions, such as antitumor effects [2,3], antihypertensive effects [4], antioxidant activity [5,6], etc.”
BackgroundMoayedi, A. A., Mora, L., Aristoy, M., Hashemi, M., Safari, M., & Toldrá, F. (2016) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-016-2198-1 · Cited by 89
Acteoside: A lipase inhibitor from the Chinese tea Ligustrum purpurascens kudingcha
Wu, X., He, W., Zhang, H., Li, Y., Liu, Z., & He, Z. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.07.071 · Cited by 87 · cited 1×
“Lipase Activity Assay Copper soap method [22]: The lipase activity assay involved a reaction medium (10 mL) containing 1 mg of olive oil, 3 mL 0.”
Method
Cited by
Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review
Rajan, L., Palaniswamy, D., & Mohankumar, S. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104681 · Cited by 195
Suryaningtyas, I. T., & Je, J. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.06.015 · Cited by 81
Vieira, M. V., Turkiewicz, I. P., Tkacz, K., Fuentes-Grünewald, C., Pastrana, L. M., Fuciños, P., Wojdyło, A., & Nowicka, P. (2021) · Molecules · doi:10.3390/molecules26247593 · Cited by 50
“[63] have reported a good inhibitory effect (47.”
BackgroundAn in vitro study of lipase inhibitory peptides obtained from de-oiled rice bran
Ketprayoon, T., Noitang, S., Sangtanoo, P., Srimongkol, P., Saisavoey, T., Reamtong, O., Choowongkomon, K., & Karnchanatat, A. (2021) · RSC Advances · doi:10.1039/d1ra01411k · Cited by 42
Anti‐obesity peptides from food: Production, evaluation, sources, and commercialization
Hajfathalian, M., Ghelichi, S., & Jacobsen, C. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70158 · Cited by 44
“Additionally, a synthetic peptide (LLVVYPWTQR), designed according to the analysis of peptides derived from C. pyrenoidosa , exhibited anti-obesity properties by inhibiting fatty acid synthesis and reducing fat accumulation in adipocytes (Zhang et al., 2019).”
Metadata
- Authors
- Zhang, R., Chen, J., Mao, X., Qi, P., & Zhang, X.
- Affiliations
- South China University of Technology (CN)
- Guangzhou Institute for Food Inspection, Guangzhou 510640, China
- Corresponding author
- Mao, Xinwu
- Zhang, Xuewu
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2019-09-29
- Volume
- 24
- Issue
- 19
- Pages
- 3527
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6804107
- OpenAlex
- W2976832584
- Semantic Scholar
- fc053900eda50c20af968e4fd51f29e47b8fa3b2
- Cited by
- 34
- References
- 22
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 8 · 2023: 8 · 2022: 3 · 2021: 2 · 2020: 3
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
- Keywords
- decapeptide, Chlorella pyrenoidosa, triglyceride accumulation, 3T3-L1 adipocytes, non-alcoholic fatty liver disease, AMPK signaling, SREBP-1c, PPARγ, C/EBPα, fatty acid synthesis, obesity, peptide synthesis, molecular docking
- MeSH terms
- Amino Acid Sequence, Animals, Chlorella, Dose-Response Relationship, Drug, Chemical Fractionation, Hydrolysis, Models, Molecular, Molecular Weight, Oligopeptides, Plant Extracts, Protein Conformation, Swine, Pancrelipase, 3T3-L1 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose. https://app.cochat.ai/papers/10.3390/molecules24193527
- The paper
- Zhang, R., Chen, J., Mao, X., Qi, P., & Zhang, X. (2019). Separation and Lipid Inhibition Effects of a Novel Decapeptide from Chlorella pyenoidose. Molecules. https://doi.org/10.3390/molecules24193527
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.